Notice of Changes in Directors

CMIC HOLDINGS Co., Ltd. announces that it decided at a meeting of its Board of Directors held today to submit the changes in directors to the 38th annual shareholders’ meeting to be held on December 15, 2022.

1. Changes in Board of Directors

（1） New candidate for the Corporate Directors (to be submitted to the annual shareholders’ meeting to be held on December 15, 2022)

Corporate Director
Akihisa Mitake （Division Director of CRO Business（Clinical CRO)）

External Corporate Director
Masaru Ota （External Audit and Supervisory Board Member）
*Mr. Ota will resign as an external audit and supervisory board member at the conclusion of the annual shareholders’ meeting to be held on December 15, 2022.

（2） New candidate for the Audit and Supervisory Board Member (to be submitted to the annual shareholders’ meeting to be held on December 15, 2022)

Audit and Supervisory Board Member
Takanori Tobe （CMIC HealthCare Institute Co., Ltd.　Managing Director）

External Audit and Supervisory Board Member
Hidetoshi Watanabe （External Audit and Supervisory Board Member）

External Audit and Supervisory Board Member
Eiko Hakoda （Mori Hamada & Matsumoto　LPC Partner）

（3） Corporate Directors to be retired (their term to be expired at the annual shareholders’ meeting to be held on December 15, 2022)

Corporate Director Toru Fujieda
Corporate Director Yoshiyuki Inamoto
External Corporate Director Eriko Kawai

（4）Audit and Supervisory Board Member to be retired (their term to be expired at the annual shareholders’ meeting to be held on December 15, 2022)

Audit and Supervisory Board Member Yasuo Yoshimune